How to Identify Migraine Triggers and Prevent Attacks in Colorado Springs

Migraine is not simply bad headaches. It is a complex neurological disorder affecting over 39 million Americans, characterized by recurring attacks of moderate-to-severe throbbing pain, often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. For the millions who live with migraine, each attack is not merely painful but disruptive: derailing workdays, canceling plans, and eroding quality of life with an unpredictability that generates its own chronic anxiety.

One of the most empowering and most frequently overlooked aspects of migraine management is trigger identification. Migraines rarely arise from nowhere. They are typically the culmination of multiple biological stressors accumulating past a personal threshold, with identifiable triggers contributing to that accumulation. Understanding your specific triggers, the dietary, environmental, hormonal, sleep-related, and stress-related factors that push your nervous system toward attack, is the foundation of effective prevention.

For Colorado Springs residents, trigger identification and prevention planning carry particular relevance. The city’s high altitude (6,035 feet), frequent weather and barometric pressure changes, and intense solar exposure create a distinct environmental migraine risk profile that requires locally-informed management. BioFunctional Health Solutions in Colorado Springs offers comprehensive migraine evaluation and prevention programs designed to identify your specific trigger pattern and build a prevention strategy tailored to your neurobiology and lifestyle.

Common Migraine Triggers

Migraine triggers are not causes; they are threshold contributors. The migraine brain has a lower-than-average tolerance for neurological perturbation, and triggers are the stimuli that push neurological activity past the threshold at which a migraine cascade initiates. This is why the same trigger does not produce a migraine every time: if other stressors are low, the threshold may not be crossed; if multiple triggers accumulate simultaneously, even a normally tolerable stimulus may initiate an attack.

This threshold model also explains why trigger identification requires systematic observation rather than single-incident recall. A detailed headache diary, tracking food, sleep, stress, hormonal cycle phase, weather, hydration, exercise, and other variables alongside migraine onset, is the most clinically reliable tool for identifying personal trigger patterns. BioFunctional Health Solutions provides structured migraine diary protocols and digital tracking tools as part of the initial evaluation process.

Food and Diet: Caffeine, Processed Foods, and MSG

Dietary triggers are among the most commonly reported and most amenable to patient-directed management. However, the relationship between food and migraine is more complex than simple cause-and-effect: the same food may trigger a migraine when combined with sleep deprivation or hormonal flux, but not when consumed under low-stress, well-rested conditions.

The Most Evidence-Supported Dietary Migraine Triggers

• Caffeine: Caffeine has a paradoxical relationship with migraine: in moderate amounts, it is vasoconstrictive and acutely analgesic (hence its inclusion in some migraine medications), but regular consumption creates caffeine dependence and withdrawal, even from a single missed morning cup, reliably triggers migraine in susceptible individuals. Daily caffeine intake above 200mg and abrupt reduction are the primary culprits. Gradual tapering and consistent dosing (same amount at the same time daily) minimize this trigger.
  
• MSG (monosodium glutamate): MSG is a glutamate salt used extensively as a flavor enhancer in processed foods, fast food, soups, seasonings, chips, and Asian restaurant cuisine. Glutamate is an excitatory neurotransmitter, and excess dietary glutamate is hypothesized to lower the cortical spreading depression threshold in migraine-susceptible individuals. Hidden sources of MSG include autolyzed yeast extract, hydrolyzed protein, and natural flavoring labels.
  
• Tyramine-containing foods: Tyramine is a vasoactive amine formed through the aging or fermentation of protein-rich foods. It promotes norepinephrine release, which can trigger vascular changes associated with migraine in susceptible individuals. High-tyramine foods include aged cheeses (Parmesan, blue cheese, aged cheddar), cured and processed meats (salami, pepperoni, hot dogs), red wine, soy sauce, and vinegar.
  
• Alcohol (especially red wine): Red wine is the most commonly reported alcohol trigger, likely through a combination of tyramine, sulfites, tannins, and direct vasodilatory effects. Even small amounts (1-2 glasses) trigger migraine in some patients within hours; others experience delayed triggers appearing the following day. White wine, beer, and spirits vary in trigger potential by individual.
• Artificial sweeteners (aspartame, sucralose): Aspartame is metabolized to phenylalanine and aspartate, both neuroactive compounds, and has been implicated as a migraine trigger in multiple case series and patient surveys. Diet sodas, sugar-free gum, and “light” food products are primary sources.
  
• Skipping meals and blood glucose variability: Irregular eating patterns and prolonged fasting produce hypoglycemia that is a well-established migraine trigger, likely through hypothalamic activation of pain-sensitizing pathways. Consistent meal timing and adequate carbohydrate intake to maintain stable blood glucose are as important as avoiding specific trigger foods.

Dietary Prevention Strategies

• Elimination and reintroduction approach: Systematically removing high-probability trigger foods for 4-6 weeks, then reintroducing one at a time, is the gold-standard method for confirming dietary triggers. This requires a structured protocol that BioFunctional Health Solutions provides as part of the dietary component of migraine evaluation.
  
• Anti-inflammatory dietary pattern: The Mediterranean diet reduces systemic inflammation and improves vascular function, both relevant to migraine pathophysiology. Emphasis on omega-3-rich fish, abundant vegetables, olive oil, and whole grains has been associated with reduced migraine frequency in observational studies.
  
• Magnesium repletion through diet and supplementation: Magnesium deficiency is one of the most consistent biological findings in migraine patients. Dietary magnesium from dark leafy greens, nuts, seeds, and legumes, supplemented with magnesium glycinate (400-600mg/day), has Level A evidence for migraine prevention from the American Academy of Neurology.

Stress and Mental Health

Stress is the most universally reported migraine trigger across populations, reported by 50-80% of migraine patients as a significant precipitant. The relationship operates through multiple biological pathways: acute stress activates the HPA axis, releasing cortisol and norepinephrine that modulate trigeminovascular activity; chronic stress reduces the migraine threshold through sustained neuroinflammatory changes; and paradoxically, the “letdown” after a period of high stress, the weekend migraine phenomenon, is as common as stress-during episodes.

Neurobiological Mechanisms of Stress-Triggered Migraine

• CRH and cortisol release: Corticotropin-releasing hormone (CRH) released during stress directly activates mast cells in the meninges, triggering neuroinflammatory processes that lower the trigeminal pain threshold. Acute cortisol spikes also produce vascular changes that contribute to migraine initiation.
  
• Serotonin dysregulation: Stress depletes central serotonin reserves over time, and acute stress produces transient serotonin surges followed by rapid drops, a pattern consistent with the prodromal and pain phases of migraine. The migraine brain’s serotonergic system is already sensitized, making it especially vulnerable to stress-related depletion.
  
• Sensitization of the trigeminovascular system: Chronic psychological stress produces central sensitization of the trigeminal pathway, the pain-processing network central to migraine, lowering the threshold for subsequent attacks from any trigger category. This explains why stress reduction produces benefits that extend beyond the direct reduction of stress-triggered migraines.

Evidence-Based Stress Reduction for Migraine Prevention

• Cognitive Behavioral Therapy (CBT) for migraine: CBT adapted for headache disorders produces significant reductions in migraine frequency and headache-related disability, comparable to pharmacological prevention in multiple RCTs. CBT addresses both psychological stress triggers and the maladaptive pain cognitions that amplify migraine suffering.
  
• Biofeedback (thermal and EMG): Biofeedback, training patients to consciously regulate physiological parameters like hand temperature (reflecting peripheral vasoconstriction) and frontalis muscle tension, has Level A evidence from the American Academy of Neurology for migraine prevention, comparable to propranolol. It is particularly valuable because it produces durable self-regulation skills rather than passive treatment effects.
  
• Mindfulness-Based Stress Reduction (MBSR): Eight-week MBSR programs reduce migraine frequency, attack duration, and headache-related disability in controlled trials, with mechanisms including reduced amygdala reactivity, lower cortisol, and improved pain catastrophizing.

Sleep Patterns and Circadian Rhythm

The relationship between sleep and migraine is bidirectional and clinically significant: disrupted sleep triggers migraines, and migraines disrupt sleep, creating a reinforcing cycle that can substantially worsen chronicity if not deliberately interrupted. Both too much and too little sleep are documented triggers, making consistent sleep duration and timing, rather than simply “more sleep,” the target of intervention.

• Sleep deprivation: Even a single night of restricted sleep (less than 6 hours) lowers the migraine threshold through increased pain sensitivity, cortisol elevation, and impaired serotonergic regulation. Chronic sleep deprivation is associated with significantly higher migraine frequency and a greater risk of episodic migraine evolving to chronic migraine (15+ headache days/month).
  
• Oversleeping (weekend migraine): Saturday morning migraine is a classic presentation, attributed to sleeping later than usual, which delays morning caffeine intake (withdrawal), disrupts cortisol awakening response, and may alter serotonin release timing. Maintaining a consistent wake time seven days per week is one of the most clinically impactful sleep interventions for migraine prevention.
  
• Sleep architecture disruption: Migraine attacks preferentially initiate during REM sleep, suggesting that disruption of sleep stages, by sleep apnea, insomnia, restless legs, or sleep-disordered breathing, creates a neurological vulnerability window. Screening for obstructive sleep apnea is particularly important in migraine patients, as CPAP treatment measurably reduces migraine frequency in patients with comorbid OSA.
  
• Circadian misalignment: Shift work, irregular sleep schedules, and chronic jet lag disrupt the circadian regulation of serotonin, melatonin, and cortisol, all neurotransmitters with direct roles in migraine modulation. Melatonin supplementation (3-10mg nightly) has emerging Level B evidence for migraine prevention, likely through circadian stabilization and antinociceptive properties.

Hormonal Changes

Migraine is three times more prevalent in women than men following puberty, a disparity that largely disappears after menopause in most patients, providing compelling evidence that reproductive hormones are major modulators of migraine susceptibility. Estrogen, in particular, exerts broad influences on the trigeminovascular system, serotonin signaling, and neuroinflammatory pathways that are central to migraine pathophysiology.

Key Hormonal Migraine Patterns

• Menstrual migraine (perimenstrual attacks): Approximately 50-60% of female migraine patients report attacks reliably occurring within the 2 days before to 3 days after menstrual onset, corresponding to the sharp drop in estradiol that precedes menstruation. Pure menstrual migraine (attacks only during this window) affects 10-14% of women with migraine and is frequently more severe and longer-lasting than non-menstrual attacks, with poorer response to standard treatment.
  
• Oral contraceptive-associated migraine: Combined hormonal contraceptives (containing estrogen) can worsen migraine in some women, particularly during the pill-free week when estrogen withdrawal triggers attacks. Low-dose or continuous-cycling formulations that minimize estrogen fluctuation are preferable. Note: migraine with aura combined with combined hormonal contraceptive use carries an elevated stroke risk and requires neurological evaluation.
  
• Perimenopause: The hormonal volatility of perimenopause, characterized by irregular, unpredictable estradiol fluctuations, frequently worsens migraine frequency and severity. Stabilizing estrogen levels through bioidentical hormone replacement therapy (BHRT) with transdermal estradiol (which avoids the peaks and troughs of oral preparations) is an evidence-based approach to perimenopausal migraine prevention.
  
• Thyroid dysfunction: Both hypothyroidism and hyperthyroidism are associated with increased migraine frequency. Subclinical hypothyroidism, where TSH is mildly elevated but formal hypothyroidism criteria are not met, is frequently missed in standard evaluations and may contribute to treatment-resistant migraine. BioFunctional Health Solutions evaluates full thyroid function (including free T3, free T4, and thyroid antibodies) as part of a comprehensive migraine assessment.

Lifestyle Modifications for Prevention

Lifestyle-based migraine prevention is not a consolation prize for patients who prefer to avoid medication; it is a first-line, guideline-recommended approach with a strong evidence base that complements and frequently potentiates pharmacological prevention. The American Headache Society explicitly recommends lifestyle modification as the foundation of migraine prevention programs. The following strategies are supported by clinical evidence and are practically accessible to Colorado Springs residents.

Exercise and Posture

Regular aerobic exercise is one of the most robustly evidence-supported non-pharmacological migraine prevention strategies available. A landmark Swedish randomized trial found that 40 minutes of moderate aerobic exercise three times per week produced migraine frequency reductions equivalent to topiramate, a first-line preventive medication, with dramatically fewer side effects. Exercise exerts its preventive effects through multiple mechanisms: increasing endorphin and serotonin release, improving HPA axis regulation, reducing systemic inflammation, normalizing sleep architecture, and improving stress resilience.

Exercise Recommendations for Migraine Prevention

• Aerobic exercise (3-5 sessions/week, 30-45 min each): Moderate-intensity aerobic activity, brisk walking, cycling, swimming, or jogging, is the most studied and most effective exercise modality for migraine prevention. Intensity should be moderate rather than maximal: vigorous exercise can paradoxically trigger migraine in some patients through rapid blood pressure elevation and dehydration, particularly at Colorado Springs’ altitude.
• Warm-up and gradual intensity progression: Abrupt onset of vigorous exercise is a known migraine trigger for some patients; a 10-minute gradual warm-up reduces this risk by allowing progressive cardiovascular and metabolic adaptation.
• Consistency over intensity: Regular low-to-moderate exercise is far more protective than occasional intense exercise. Daily movement, even 20-30 minutes of walking, produces meaningful preventive effects that erratic, intense workouts do not.

Posture and Cervicogenic Migraine Prevention

Cervicogenic headache, pain originating from musculoskeletal dysfunction in the cervical spine, can trigger or exacerbate migraine through the convergence of cervical and trigeminal pain pathways. Poor screen posture (head-forward position), prolonged desk work, and chronic upper trapezius tension are particularly common contributors in the working-age population.

• Ergonomic workstation assessment: Monitor at eye level, keyboard at elbow height, chair supporting lumbar curve, and frequent postural breaks (every 25-30 minutes) reduce the cervicogenic load on the trigeminocervical complex.
  
• Physical therapy and dry needling: Targeted physical therapy addressing cervical mobility, suboccipital muscle tension, and thoracic extension has demonstrated significant migraine frequency reduction in patients with cervicogenic contributions. Dry needling of active trigger points in the upper trapezius, sternocleidomastoid, and suboccipital muscles provides particularly rapid relief.

Hydration

Dehydration is one of the most clinically consistent and most easily modifiable migraine triggers. Even mild dehydration, a body water deficit of 1-2% of body weight, produces measurable increases in pain sensitivity and has been documented to precipitate migraine in susceptible individuals within 30-60 minutes of onset.

Colorado Springs’ semi-arid climate, high altitude (which increases respiratory water loss), and frequent sunny dry days create a dehydration risk profile that exceeds that of most US cities. Additionally, the high-altitude recreational culture, hiking, skiing, and cycling, produces exertional fluid losses that many residents undercompensate for.

• Daily water target: A minimum of 1.5-2.5 liters (50-85 oz) of water per day, adjusted upward for exercise, heat, and alcohol consumption. Urine color should remain pale yellow throughout the day; dark urine is a reliable indicator of subthreshold dehydration.
  
• Electrolyte optimization: Sodium, magnesium, and potassium are electrolytes whose imbalance amplifies the neurological consequences of dehydration. Electrolyte-containing beverages or magnesium-rich mineral water provide superior migraine protection compared to plain water during high-exertion activity.
  
• Morning hydration ritual: The body is relatively dehydrated after overnight sleep (6-8 hours without fluid intake). Beginning each day with 500ml of water, ideally with a pinch of sea salt and lemon, establishes a hydration buffer before caffeine or food consumption.
  
• Alcohol and caffeine offset: Each unit of alcohol and each 100mg of caffeine has an approximately equivalent diuretic effect on fluid balance; for each drink or coffee cup, consuming an equivalent volume of water helps neutralize this trigger pathway.

Sleep Hygiene

Given the bidirectional relationship between sleep and migraine, sleep hygiene is not peripheral to migraine prevention; it is central. The most impactful sleep interventions for migraine are those that stabilize circadian timing and protect sleep architecture, not simply those that increase total sleep time.

• Consistent wake time (7 days/week, within 30 min): The single most impactful sleep intervention for migraine prevention. Fixed wake time anchors the circadian clock regardless of bedtime variability, stabilizing cortisol awakening response, melatonin onset, and serotonin rhythms, all directly relevant to migraine threshold.
  
• Morning bright light exposure (within 30 min of waking): 5-20 minutes of outdoor light exposure, Colorado Springs averages 300+ sunny days per year, making this exceptionally accessible, which provides the primary circadian zeitgeber that sets the 24-hour biological clock and determines evening melatonin onset timing.
  
• Evening blue light elimination (90 min before bed): Eliminating blue-spectrum light from screens and overhead lighting in the 90 minutes before bed preserves melatonin secretion onset, facilitating faster sleep onset, deeper slow-wave sleep, and more restful REM cycles.
  
• Bedroom temperature (65-68°F): Core body temperature must drop 1-3°F to initiate and maintain deep sleep; a cool bedroom environment supports this thermoregulatory requirement and reduces nighttime arousal frequency.
  
• Caffeine cutoff (before noon): Caffeine’s half-life is 5-7 hours; caffeine consumed after noon is still pharmacologically active at bedtime, delaying sleep onset and reducing slow-wave sleep percentage even when patients report no subjective difficulty falling asleep.

Complementary Therapies

Complementary therapies occupy an evidence-supported role in migraine prevention and acute management, not as replacements for medical care, but as meaningful adjuncts that address biological mechanisms not targeted by pharmacological treatment alone. The following approaches have the strongest evidence base among complementary modalities for migraine.

Yoga and Mindfulness

Yoga for migraine prevention has been the subject of multiple randomized controlled trials, with consistently positive findings. A 2014 RCT published in the International Journal of Yoga found that patients assigned to a structured yoga program experienced significant reductions in migraine frequency, duration, and intensity compared to conventional care alone, with effects attributable to improved vagal tone, reduced sympathetic hyperactivation, and normalized cortisol patterns.

The most clinically beneficial yoga styles for migraine patients emphasize parasympathetic activation over vigorous physical exertion:

• Hatha and Yin yoga: Slow, sustained postures with extended hold times activate the parasympathetic nervous system, reduce cervical and suboccipital muscle tension, and improve thoracic mobility, directly addressing cervicogenic migraine contributors.
  
• Yoga nidra (yogic sleep): A systematic body scan and breath awareness practice performed in a supine position; produces deep parasympathetic activation and measurable cortisol reduction within a single 30-minute session, particularly useful during migraine prodrome to potentially abort impending attacks.
  
• Pranayama (breathwork): Slow diaphragmatic breathing (5-6 breaths/minute) activates the baroreflex, increases HRV, reduces blood pressure, and directly modulates the trigeminal pain system through vagal anti-nociceptive pathways. This technique is accessible as an acute abortive strategy during early migraine warning signs.

Mindfulness-Based Stress Reduction (MBSR), discussed in the stress section, has independent evidence specifically for migraine, with a 2020 RCT demonstrating significant reduction in headache-related disability and migraine days in participants completing the 8-week program versus waitlist controls.

Massage and Tension Release

Massage therapy for migraine prevention operates through several evidence-supported mechanisms: reducing upper trapezius and suboccipital muscle tension that converges with trigeminal pain pathways, improving cervical blood flow, activating large-fiber afferents that inhibit nociceptive transmission through gate control mechanisms, and reducing cortisol while increasing serotonin and dopamine, neurotransmitters directly relevant to migraine threshold.

• Regular massage therapy (2-4 sessions/month): A systematic review of massage therapy for migraine found significant reductions in migraine frequency comparable to medication in some studies, with the best evidence for weekly sessions over 4-6 weeks followed by monthly maintenance. Effects appear to be cumulative, with greater benefit in regular versus sporadic treatment.
  
• Self-massage and suboccipital release: Daily self-massage of the suboccipital muscles (at the base of the skull) and upper trapezius with a tennis ball or massage tool provides accessible maintenance between professional sessions. Suboccipital release is particularly effective because this muscle group directly impinges on the greater occipital nerve, a key pathway in cervicogenic migraine.
  
• Trigger point therapy and dry needling: Dry needling of active myofascial trigger points in the sternocleidomastoid, upper trapezius, temporalis, and suboccipital muscles has demonstrated significant reduction in migraine frequency in multiple controlled trials, with effects exceeding those of massage alone for patients with prominent cervicogenic components. Available through BioFunctional Health Solutions’ physical medicine services.

Acupuncture

Acupuncture has one of the most robust evidence bases of any complementary therapy for migraine, with multiple large-scale randomized trials and a positive Cochrane systematic review. A 2016 Cochrane review of 22 trials found that acupuncture was at least as effective as pharmacological migraine prevention, produced migraine frequency reductions of approximately 50% in responders, and carried substantially fewer adverse effects than preventive medications.

The neurobiological mechanisms proposed for acupuncture’s efficacy in migraine include:

• Endogenous opioid release (beta-endorphin, enkephalin) at acupuncture points
• Serotonin modulation through dorsal raphe nucleus stimulation
• CGRP (calcitonin gene-related peptide) reduction, the same neuropeptide targeted by the newest class of migraine-specific preventive medications (gepants and anti-CGRP monoclonal antibodies)
• Hypothalamic and limbic modulation of pain processing networks documented by fMRI

Treatment protocol: Optimal acupuncture protocols for migraine prevention typically involve 6-12 sessions over 8-12 weeks, followed by monthly maintenance. Traditional Chinese medicine, acupuncture and dry needling protocols both demonstrate efficacy in the trial literature, with slight advantages for Traditional protocols in some meta-analyses.

Colorado Springs access: BioFunctional Health Solutions coordinates with licensed acupuncturists within our network and integrates acupuncture as a component of comprehensive migraine prevention programs where clinically indicated.

When to Seek Professional Help

While self-directed trigger management and lifestyle modification can produce meaningful improvement for many migraine sufferers, professional evaluation and treatment are warranted in a significant proportion of cases. Knowing when to escalate from self-management to professional care is itself an important part of effective migraine management.

Frequency and Severity of Attacks

The following clinical indicators suggest that professional evaluation is needed promptly:

• Four or more migraine days per month: This threshold is the standard clinical criterion for initiating preventive therapy. Below this frequency, acute treatment of individual attacks may be sufficient; at or above this level, the cumulative impact on function, quality of life, and risk of chronification warrants preventive intervention.
  
• Significant functional impairment: If migraines are causing missed work or school days, canceled social obligations, or substantially reduced productivity, regardless of absolute frequency, professional evaluation is warranted. Validated disability tools like the MIDAS (Migraine Disability Assessment) and HIT-6 (Headache Impact Test) quantify this impact and help guide treatment decisions.
  
• Increasing frequency trend: Episodic migraine transitions to chronic migraine (15+ headache days per month, with 8+ meeting migraine criteria) in approximately 3% of patients per year. Identifying and treating this transition early, before medication overuse, central sensitization, and structural brain changes develop, is a critical prevention goal.
  
• Medication overuse headache (MOH) risk: Using acute migraine medications (triptans, NSAIDs, combination analgesics) on 10 or more days per month produces medication overuse headache, a paradoxical worsening of headache frequency driven by the treatment itself. Professional supervision is essential for patients at or approaching this threshold.

Preventive Strategies from Healthcare Providers

A comprehensive professional migraine prevention program at BioFunctional Health Solutions encompasses several categories of evidence-based intervention:

Pharmacological Preventive Therapy

Multiple medication classes have Level A evidence (highest) for migraine prevention from the American Academy of Neurology, including: beta-blockers (propranolol, metoprolol), anticonvulsants (topiramate, valproate), antidepressants (amitriptyline, venlafaxine), and CGRP-targeting therapies. The newest class, anti-CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) and oral gepants, represents the first migraine-specific preventive medications, with response rates of 50-70% and excellent tolerability. BHS coordinates pharmacological prevention through our physician-led programs or in collaboration with neurology, where indicated.

Neurotoxin Injections (OnabotulinumtoxinA / BOTOX)

OnabotulinumtoxinA (BOTOX) is FDA-approved for chronic migraine prevention (15+ headache days/month) and produces 50%+ reduction in headache days in approximately 70% of treated patients. Injections are administered every 12 weeks across 31 sites in the head and neck, inhibiting CGRP and other neuropeptide release from trigeminovascular terminals. Response typically improves over successive treatment cycles (maximum benefit often at cycle 3-4).

Advanced Diagnostic Evaluation

BioFunctional Health Solutions’ comprehensive migraine assessment includes: complete hormonal panel (estradiol, progesterone, testosterone, thyroid panel, DHEA-S, cortisol); metabolic and inflammatory biomarkers (hs-CRP, homocysteine, fasting insulin, HbA1c); micronutrient evaluation (magnesium RBC, vitamin D, B12, CoQ10); screening for sleep-disordered breathing; and neurofeedback assessment for the cortical hyperexcitability characteristic of the migraine brain. This multi-dimensional evaluation identifies biological contributors that conventional neurology does not routinely assess, and enables interventions targeted at the specific neurobiological vulnerabilities driving each patient’s migraine pattern.

Neurofeedback for Migraine Prevention

The migraine brain demonstrates characteristic cortical hyperexcitability, an excessive reactivity to sensory input and internal neural perturbations that directly lower the migraine threshold. Neurofeedback training that specifically targets the normalization of cortical excitability patterns has demonstrated significant migraine frequency reduction in multiple studies. BioFunctional Health Solutions offers neurofeedback as part of integrated migraine prevention programs, particularly for patients who prefer non-pharmacological approaches or who have not achieved adequate response to conventional preventive medications.

Frequently Asked Questions

Can triggers change over time?

Yes, and this is one of the most clinically important and most frequently overlooked aspects of migraine management. Migraine triggers are not static; they evolve with age, hormonal status, lifestyle changes, stress load, and the overall neurobiological landscape of the migraine brain. A food that reliably triggers migraines in your 20s may become tolerable in your 40s, while new triggers, such as barometric pressure, hormonal fluctuations, or sleep changes, may emerge. Conversely, effective treatment that reduces overall neurological sensitization can render previously potent triggers less impactful because the threshold for initiating a migraine cascade has risen. This dynamic quality of triggers is a reason for ongoing diary-keeping and periodic reassessment with your healthcare provider, rather than a one-time trigger identification exercise. BioFunctional Health Solutions includes trigger reassessment as a standard component of all follow-up visits in our migraine management programs.

Are there medications for prevention?

Yes, multiple classes of medications have strong evidence for migraine prevention, and the field has advanced significantly in the past decade. Traditional preventives with Level A evidence include: propranolol and metoprolol (beta-blockers), topiramate and valproate (anticonvulsants), and amitriptyline (tricyclic antidepressant). These reduce migraine frequency by 50% or more in approximately 40-60% of patients but carry significant side effect profiles that limit their use in many patients. The newest generation of preventive therapies , anti-CGRP monoclonal antibodies (erenumab/Aimovig, fremanezumab/Ajovy, galcanezumab/Emgality, eptinezumab/Vyepti) and oral CGRP receptor antagonists (atogepant/Qulipta, rimegepant/Nurtec used preventively) , are the first migraine-specific preventive medications. They produce 50%+ frequency reductions in 50-70% of patients with excellent tolerability and convenient monthly or quarterly dosing. OnabotulinumtoxinA (BOTOX) is separately FDA-approved for chronic migraine. Magnesium glycinate, riboflavin (vitamin B2, 400mg/day), and CoQ10 have Level B evidence as preventive supplements with minimal side effect concerns. The optimal preventive strategy for any individual depends on their specific migraine pattern, comorbidities, prior treatment history, and personal preferences, all of which BioFunctional Health Solutions evaluates as part of comprehensive migraine care.

Book Your Migraine Evaluation in Colorado Springs

Migraine is a treatable neurological condition, but effective treatment begins with understanding the specific biological, hormonal, lifestyle, and environmental factors driving your individual attack pattern. Generic migraine advice produces generic results. A comprehensive, personalized evaluation produces a prevention program that is precisely matched to your neurobiology.

BioFunctional Health Solutions in Colorado Springs offers one of the most thorough migraine evaluations available in the region: integrating advanced hormonal and metabolic assessment, trigger identification protocols, neurofeedback evaluation, and the full range of pharmacological and non-pharmacological prevention strategies, coordinated by a physician-led team that treats migraine as the complex neurobiological condition it is.

Whether you are experiencing your first frequent migraines, have struggled with inadequate responses to previous treatments, or are seeking a comprehensive alternative to long-term medication, we can help you understand what is driving your attacks and build a prevention plan that works.